Elute, Inc
Phase 1Introducing BonVie+™: a resorbable bone graft substitute supporting natural bone restoration
Founded
2018
Focus
Drug DeliverySmall Molecules
About
Introducing BonVie+™: a resorbable bone graft substitute supporting natural bone restoration
Funding History
1Total raised: $3.2M
Seed$3.2MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile